Private Ocean’s West Pharmaceutical WST Stock Holding History

Private Ocean’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-128	Closed	-$14K	–	526
2019 Q1	$14K	Buy	+128	New	+$13.3K	﹤0.01%	303

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Private Ocean's WST Position: Q2 2019 in Review

Private Ocean sold out of West Pharmaceutical (WST) in Q2 2019, closing a stake of 128 shares — an estimated $14K sold.

Private Ocean first reported a position in WST in Q1 2019 and held it in 1 quarter. The position peaked at $14K in Q1 2019. 374 funds tracked by Wall St. Rank hold WST as of Q2 2019.

Private Ocean reported no remaining West Pharmaceutical position as of Q2 2019 after selling out during the quarter.
Private Ocean sold 128 West Pharmaceutical shares in Q2 2019, an estimated $14K.
Private Ocean first reported a position in West Pharmaceutical in Q1 2019 and held it in 1 quarter.
Private Ocean's West Pharmaceutical position peaked at $14K in Q1 2019.
374 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2019.

Based on Private Ocean's 13F filing for Q2 2019, filed 30 Jul 2019.